[HTML][HTML] Therapeutic advantage of combinatorial CAR T cell and chemo-therapies
MB Ward, AB Jones, G Krenciute - Pharmacological Reviews, 2024 - Elsevier
Chimeric antigen receptor (CAR) T cell therapies have transformed outcomes for many
patients with hematological malignancies. However, some patients do not respond to CAR T …
patients with hematological malignancies. However, some patients do not respond to CAR T …
[HTML][HTML] Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapies
MB Ward, AB Jones… - Pharmacological …, 2025 - pharmrev.aspetjournals.org
Chimeric antigen receptor (CAR) T cell therapies have transformed outcomes for many
patients with hematological malignancies. However, some patients do not respond to CAR T …
patients with hematological malignancies. However, some patients do not respond to CAR T …
[HTML][HTML] Tumor cells ectopically expressing the membrane-bound form of IL-7 develop an antitumor immune response efficiently in a colon carcinoma model
HS Shin, H Kim, SG Kwon, H Lee, JO Lee, YS Kim - Molecules and Cells, 2024 - Elsevier
Various approaches employing cytokines and cytokine gene-modified tumor cells have
been explored to induce antitumor responses, yet their widespread application has been …
been explored to induce antitumor responses, yet their widespread application has been …
Advances in IL-7 Research on Tumour Therapy
C Fu, X Zhang, X Zhang, D Wang, S Han, Z Ma - Pharmaceuticals, 2024 - mdpi.com
Interleukin-7 (IL-7) is a versatile cytokine that plays a crucial role in regulating the immune
system's homeostasis. It is involved in the development, proliferation, and differentiation of B …
system's homeostasis. It is involved in the development, proliferation, and differentiation of B …